Trastuzumab Recruiting Phase 2 Trials for Malignant Neoplasm of Stomach / Esophageal Cancers Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02954536Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer
NCT02725424Optimizing the Strategy for Preoperative Chemotherapy in Locally Advanced Gastric/Gastroesophageal Cancer
NCT02250209T- XELOX in HER2-positive Stage III Gastric Cancer After D2 Gastrectomy